Akebia Therapeutics, Inc. (AKBA) Strengthens Vafseo Patent Protection Through 2036
We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Akebia Therapeutics, Inc.
Posts Tagged ‘NASDAQ:AKBA’
12 Best Low-Priced Pharma Stocks to Buy Right Now
Investors looking for large returns without making a sizable initial commitment are still drawn to low-priced companies.
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2026 Earnings Call Transcript
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2026 Earnings Call Transcript May 7, 2026Akebia Therapeutics, Inc. misses on earnings expectations.
10 Best Penny Stocks That Could Triple Your Money
In this article, we will take a look at the 10 best penny stocks that are currently offering more than 200% upside potential to investors.
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2025 Earnings Call Transcript
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2025 Earnings Call Transcript February 26, 2026Akebia Therapeutics, Inc. misses on earnings expectations.
Piper Sandler Lowers Akebia Therapeutics (AKBA) PT to $4 as Firm Updates Estimates Following Year-End Reports
Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the best growth stocks to buy for the next 20 years.
10 Best Growth Stocks to Buy for the Next 20 Years
On February 13, Chief Market Strategist at Carson Group Ryan Detrick and CEO of MCC Global Enterprises Michelle Caruso-Cabrera joined CNBC to discuss rising geopolitical tensions...
Akebia Therapeutics Expands Portfolio Beyond Anemia with New Rare Kidney Disease Pipeline Centered on AKB-097 and Praliciguat
Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the cheap penny stocks to invest in.
11 Cheap Penny Stocks to Invest In
On December 17, Lale Akoner, Global Market Analyst at eToro, appeared on CNBC to suggest that she is observing capital moving away from high-multiple mega-cap stocks and toward...
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q3 2025 Earnings Call Transcript
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q3 2025 Earnings Call Transcript November 10, 2025Akebia Therapeutics, Inc. beats earnings expectations.
Akebia Therapeutics (AKBA) Bounces to Profitability amid Kidney Treatment Growth
Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the best multibagger penny stocks to buy according to analysts.
13 Best Multibagger Penny Stocks to Buy According to Analysts
It’s time to pivot towards micro and small-cap stocks as the US Federal Reserve prepares to cut interest rates.
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q2 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Akebia Second Quarter 2025 Financial Results.
10 Best Performing Penny Stocks So Far in 2025
By midday Wednesday, July 23, 2025, the Russell 2000 was up 1.57% for the week. This compares to a 0.9% gain for the S&P 500.
Akebia Therapeutics (AKBA) Kidney Therapy Vafseo Gaining Market Share
Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the best high-return penny stocks to buy now. On July 14, 2025, Akebia shared key updates during the H.C.
11 Best High Return Penny Stocks to Buy Now
US equity markets are back at all-time highs amid a muted response to new U.S. tariffs and the trade war.
Leerink Partners Reiterates a Buy Rating on Akebia Therapeutics (AKBA) With a $7 PT
Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the 13 Stocks Under $5 With High Upside Potential.
13 Stocks Under $5 With High Upside Potential
On July 1, Ralph Schlosstein, Evercore chairman emeritus and BlackRock co-founder, appeared on CNBC's 'Closing Bell Overtime' to discuss his outlook for markets heading into the...
Akebia Therapeutics, Inc. (AKBA) Shareholders Greenlight 18.9 Million Share Increase
Akebia Therapeutics, Inc. (NASDAQ:AKBA) is among the best growth stocks to invest in for the next 5 years. Akebia Therapeutics, Inc.
12 Small Cap Stocks with High Upside Potential
The trade war saga between the U.S. and China appears to be nearing a conclusion, as China’s Ministry of Commerce shared details on the trade deal on June 27.
Akebia Therapeutics Reports Positive Results from its Vadadustat Global Phase 3 Clinical Trials
Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the 12 Small Cap Stocks with High Upside Potential.
Akebia Therapeutics (AKBA) Grants Stock Options to New Employees
Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the 10 best healthcare penny stocks to buy according to analysts.
10 Best Healthcare Penny Stocks to Buy According to Analysts
According to the Centers for Medicare & Medicaid Services (CMS), the US healthcare sector accounted for approximately 17.6% of GDP in 2023.
15 Best Growth Stocks to Invest in for the Next 5 Years
Before making any decision, whether big or small, we instinctively weigh its long-term impact, and this is particularly true in the case of stocks.
H.C. Wainwright Initiates Coverage of Akebia Therapeutics (AKBA) With Buy Rating
Matthew Caufield, an analyst from H.C. Wainwright, initiated coverage of Akebia Therapeutics, Inc. (NASDAQ:AKBA) with a Buy rating and a $8 price target, on June 4.
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2025 Earnings Call Transcript
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2025 Earnings Call Transcript May 8, 2025Akebia Therapeutics, Inc. beats earnings expectations.
12 Best Stocks to Invest in for a Stock Market Game
We all have heard the phrase ‘value isn’t always visible at first glance’ at least once in our lifetime and this isn’t something to overlook, particularly when you are...
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2024 Earnings Call Transcript
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2024 Earnings Call Transcript March 13, 2025Akebia Therapeutics, Inc. misses on earnings expectations.
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q3 2024 Earnings Call Transcript
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q3 2024 Earnings Call Transcript November 7, 2024Akebia Therapeutics, Inc. misses on earnings expectations.
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript
Akebia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.08775, expectations were $-0.09.
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q3 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Akebia Therapeutics' Third Quarter 2023 Financial Results Conference Call.
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q2 2023 Earnings Call Transcript
Operator: Good day and welcome to Akebia's Second Quarter 2023 Financial Results Call. At this time, all participants are in a listen-only mode.
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Akebia's First Quarter 2023 Financial Results Conference Call.
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2022 Earnings Call Transcript
Operator: Good day ladies and gentlemen. Thank you for standing by and welcome to Akebia's Fourth Quarter 2022 Financial Results Conference Call.
5 Underperforming Stocks Targeted By Short Sellers
In this article we discuss top 5 underperforming stocks targeted by short sellers.
Is AKBA A Good Stock To Buy Now?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Have Never Been This Bullish On Akebia Therapeutics Inc (AKBA)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Were Hedge Funds Right About Warming Up To Akebia Therapeutics Inc (AKBA)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Are Buying Akebia Therapeutics Inc (AKBA)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Did Hedge Funds Drop The Ball On Akebia Therapeutics Inc (AKBA) ?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Akebia Therapeutics Inc (AKBA) Is Burning These Hedge Funds
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock...
Hedge Funds Are Dumping Akebia Therapeutics Inc (AKBA)
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions of dollars of accredited...
Here’s What Hedge Funds Think About Akebia Therapeutics Inc (AKBA)
The market has been volatile in the fourth quarter as the Federal Reserve continued its rate hikes to normalize the interest rates.
Hedge Funds Are Crazy About Akebia Therapeutics Inc (AKBA)
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
33 Recent Stories Telling How The Financial Markets Are Doing Today
"U.S. stocks pulled back on Tuesday after the S&P 500 and the Nasdaq Composite hit record intraday highs as a decline in healthcare stocks offset gains in technology.
Markets Snapshot: 35 Major Stories About The Financial Markets Today
"U.S. equities held most of their gains on Wednesday as investors digested President Donald Trump's outline for tax reform, while earnings season continued.
Akebia Therapeutics Inc (AKBA) Sells Partial US Rights For Vadadustat To Otsuka
Akebia Therapeutics Inc (NASDAQ:AKBA) has surrendered 50% of U.S.
Is Akebia Therapeutics Inc (AKBA) A Good Stock To Buy?
The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous ...
Calculating The Impact Of Akebia Therapeutics Inc (AKBA)’s Pivotals
Akebia Therapeutics Inc (NASDAQ:AKBA) just gave word of the initiation of its pivotal trial in a second indication for its lead renal anemia candidate, Vadadustat.
Hedge Fund Resource Center
